Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1755 ARTÍCULOS , VIENDO DEL 436 AL 450

Exploring links between 2-oxoglutarate-dependent oxygenases and Alzheimer's disease

Liu H, Xie Y, Wang X, Abboud MI, Ma C, Ge W, Schofield CJ.

Alzheimers Dement. 2022 Dec;18(12):2637-2668. doi: 10.1002/alz.12733. Epub 2022 Jul 19.

Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease

Zhang H, Wang Y, Wang Y, Li X, Wang S, Wang Z.

Eur J Med Chem. 2022 Oct 5;240:114606. doi: 10.1016/j.ejmech.2022.114606. Epub 2022 Jul 16.

Is Air Pollution Associated with Increased Risk of Dementia? A Meta-Analysis of Epidemiological Research

Dhiman V, Trushna T, Raj D, Tiwari RR.

Neurol India. 2022 May-Jun;70(3):1004-1019. doi: 10.4103/0028-3886.349654.

A Review of African Medicinal Plants and Functional Foods for the Management of Alzheimer's Disease-related Phenotypes, Treatment of HSV-1 Infection and/or Improvement of Gut Microbiota

Tettevi EJ, Maina M, Simpong DL, Osei-Atweneboana MY, Ocloo A.

J Evid Based Integr Med. 2022 Jan-Dec;27:2515690X221114657. doi: 10.1177/2515690X221114657.

Dysregulated miRNAs in Progression and Pathogenesis of Alzheimer's Disease

Arora T, Prashar V, Singh R, Barwal TS, Changotra H, Sharma A, Parkash J.

Mol Neurobiol. 2022 Oct;59(10):6107-6124. doi: 10.1007/s12035-022-02950-z. Epub 2022 Jul 22.

Pivotal role of nitrogen heterocycles in Alzheimer's disease drug discovery

Kumari S, Maddeboina K, Bachu RD, Boddu SHS, Trippier PC, Tiwari AK.

Drug Discov Today. 2022 Oct;27(10):103322. doi: 10.1016/j.drudis.2022.07.007. Epub 2022 Jul 19.

The effect of dietary fat consumption on Alzheimer's disease pathogenesis in mouse models

Amelianchik A, Sweetland-Martin L, Norris EH.

Transl Psychiatry. 2022 Jul 22;12(1):293. doi: 10.1038/s41398-022-02067-w.

Adenosine receptor signalling in Alzheimer's disease

Trinh PNH, Baltos JA, Hellyer SD, May LT, Gregory KJ.

Purinergic Signal. 2022 Sep;18(3):359-381. doi: 10.1007/s11302-022-09883-1. Epub 2022 Jul 23.

Towards development of disease-modifying therapy for Alzheimer's disease using redox chemical biology pathways

Lipton SA.

Curr Opin Pharmacol. 2022 Oct;66:102267. doi: 10.1016/j.coph.2022.102267. Epub 2022 Jul 20.

Astrocyte energy and neurotransmitter metabolism in Alzheimer's disease: Integration of the glutamate/GABA-glutamine cycle

Andersen JV, Schousboe A, Verkhratsky A.

Prog Neurobiol. 2022 Oct;217:102331. doi: 10.1016/j.pneurobio.2022.102331. Epub 2022 Jul 21.

Role of Shankhpushpi (Convolvulus pluricaulis) in neurological disorders: An umbrella review covering evidence from ethnopharmacology to clinical studies

Sharma R, Singla RK, Banerjee S, Sinha B, Shen B, Sharma R.

Neurosci Biobehav Rev. 2022 Sep;140:104795. doi: 10.1016/j.neubiorev.2022.104795. Epub 2022 Jul 22.

Is Alzheimer's disease an infectious neurological disease? A review of the literature

Uwishema O, Mahmoud A, Sun J, Correia IFS, Bejjani N, Alwan M, Nicholas A, Oluyemisi A, Dost B.

Brain Behav. 2022 Aug;12(8):e2728. doi: 10.1002/brb3.2728. Epub 2022 Jul 25.

Pharmacotherapy of Alzheimer's disease: an overview of systematic reviews

Majidazar R, Rezazadeh-Gavgani E, Sadigh-Eteghad S, Naseri A.

Eur J Clin Pharmacol. 2022 Oct;78(10):1567-1587. doi: 10.1007/s00228-022-03363-6. Epub 2022 Jul 26.

Amylin and Secretases in the Pathology and Treatment of Alzheimer's Disease

Singh S, Yang F, Sivils A, Cegielski V, Chu XP.

Biomolecules. 2022 Jul 17;12(7):996. doi: 10.3390/biom12070996.

Comparison of Tau and Amyloid-β Targeted Immunotherapy Nanoparticles for Alzheimer's Disease

Mashal Y, Abdelhady H, Iyer AK.

Biomolecules. 2022 Jul 18;12(7):1001. doi: 10.3390/biom12071001.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias